The spurious advance of antipsychotic drug therapy-Reference-Cited by-同舟云学术

The spurious advance of antipsychotic drug therapy

Published:2009-01 Issue:9657 Volume:373 Page:4-5
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Tyrer Peter,Kendall Tim

Publisher

Elsevier BV

Subject

General Medicine

Reference14 articles.

1. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis;Leucht;Lancet,2008

2. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties;Janssen;J Pharmacol Exp Ther,1988

3. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia;Lieberman;N Engl J Med,2005

4. Randomized controlled trial of effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1);Jones;Arch Gen Psychiatry,2006

5. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial;Keefe;Arch Gen Psychiatry,2007

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antipsychotics in the Management of Disruptive Behavior Disorders in Children and Adolescents: An Update and Critical Review;Biomedicines;2022-11-04

2. American psychiatry in the new millennium: a critical appraisal;Psychological Medicine;2021-06-23

3. Minimal Self Disorders in Schizophrenia;Turkish Journal of Psychiatry;2021

4. Optimal Parameters of Deep Brain Stimulation in Essential Tremor: A Meta-Analysis and Novel Programming Strategy;Journal of Clinical Medicine;2020-06-14

5. Methods of synthesis of Pimavanserin: the first drug approved for the treatment of Parkinson's disease psychosis (PDP);Arkivoc;2020-02-03